Literature DB >> 26165861

New composites of betulin esters with arabinogalactan as highly potent anti-cancer agents.

T P Shakhtshneider1,2, S A Kuznetsova3,4, A S Zamay3,5, T N Zamay5, E A Spivak5, M A Mikhailenko1, Yu N Malyar3, B N Kuznetsov3,4, N V Chesnokov3,4, V V Boldyrev1,2.   

Abstract

Betulin and its esters are the natural compounds with high in vitro cytotoxicity toward many cancer cells. However, the poor water solubility of these compounds has limited their applications. We prepared new composites of betulin esters using two methods, namely ball-milling of the mixtures of betulin esters with arabinogalactan and preparation of thin films of these mixtures by evaporating the aqueous solutions. These composites revealed higher water solubility as compared with the initial substances without losing the structural integrity and functionality. As a result, the new composites have shown much higher inhibitory effects against different cancer cell lines such as Ehrlich ascites carcinoma cells and lung carcinoma cells (A549) in comparison with the initial substances. The cell viability studies based on Annexin V and Propidium iodide probes have confirmed the high proapoptotic effect of betulin ester derivatives against cancer cells.

Entities:  

Keywords:  anticancer activity; arabinogalactan; betulin diacetate; betulin dipropionate; composites; solubility

Mesh:

Substances:

Year:  2015        PMID: 26165861     DOI: 10.1080/14786419.2015.1060591

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  2 in total

Review 1.  Secondary Metabolites with Biomedical Applications from Plants of the Sarraceniaceae Family.

Authors:  Ileana Miclea
Journal:  Int J Mol Sci       Date:  2022-08-30       Impact factor: 6.208

2.  Neuroprotective Effects of Betulin in Pharmacological and Transgenic Caenorhabditis elegans Models of Parkinson's Disease.

Authors:  Chia-Wen Tsai; Rong-Tzong Tsai; Shih-Ping Liu; Chang-Shi Chen; Min-Chen Tsai; Shao-Hsuan Chien; Huey-Shan Hung; Shinn-Zong Lin; Woei-Cherng Shyu; Ru-Huei Fu
Journal:  Cell Transplant       Date:  2017-12       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.